Chi-square tests analyzing the relationship between CRISP2 expression levels and various clinical traits, illustrated in Figure 7B, showed significant associations with factors including gender, PAM50 subtypes, tumor stage, age, ER status, PR status, HER2 status, and treatment types. This evidence concerns the gene CRISP2 and neoplasm.